T0	KEYPHRASE-NOTYPES 0 4	Bell
T1	KEYPHRASE-NOTYPES 7 12	palsy
T2	KEYPHRASE-NOTYPES 39 66	unilateral facial paralysis
T3	KEYPHRASE-NOTYPES 75 91	annual incidence
T4	KEYPHRASE-NOTYPES 149 161	common cause
T5	KEYPHRASE-NOTYPES 165 192	unilateral facial paralysis
T6	KEYPHRASE-NOTYPES 204 207	men
T7	KEYPHRASE-NOTYPES 212 217	women
T8	KEYPHRASE-NOTYPES 244 254	median age
T9	KEYPHRASE-NOTYPES 258 263	onset
T10	KEYPHRASE-NOTYPES 270 275	years
T11	KEYPHRASE-NOTYPES 297 300	age
T12	KEYPHRASE-NOTYPES 306 314	Patients
T13	KEYPHRASE-NOTYPES 320 324	Bell
T14	KEYPHRASE-NOTYPES 327 332	palsy
T15	KEYPHRASE-NOTYPES 366 383	complete weakness
T16	KEYPHRASE-NOTYPES 391 398	muscles
T17	KEYPHRASE-NOTYPES 402 406	half
T18	KEYPHRASE-NOTYPES 414 418	face
T19	KEYPHRASE-NOTYPES 436 445	inability
T20	KEYPHRASE-NOTYPES 455 463	eyebrows
T21	KEYPHRASE-NOTYPES 465 472	wrinkle
T22	KEYPHRASE-NOTYPES 477 485	forehead
T23	KEYPHRASE-NOTYPES 500 506	eyelid
T24	KEYPHRASE-NOTYPES 508 512	loss
T25	KEYPHRASE-NOTYPES 520 535	nasolabial fold
T26	KEYPHRASE-NOTYPES 557 562	angle
T27	KEYPHRASE-NOTYPES 570 575	mouth
T28	KEYPHRASE-NOTYPES 594 602	symptoms
T29	KEYPHRASE-NOTYPES 611 622	alterations
T30	KEYPHRASE-NOTYPES 626 631	taste
T31	KEYPHRASE-NOTYPES 633 644	hyperacusis
T32	KEYPHRASE-NOTYPES 646 655	inability
T33	KEYPHRASE-NOTYPES 667 672	tears
T34	KEYPHRASE-NOTYPES 680 698	subjective feeling
T35	KEYPHRASE-NOTYPES 702 717	facial numbness
T36	KEYPHRASE-NOTYPES 726 745	objective sensation
T37	KEYPHRASE-NOTYPES 760 780	nThe pathophysiology
T38	KEYPHRASE-NOTYPES 784 788	Bell
T39	KEYPHRASE-NOTYPES 791 796	palsy
T40	KEYPHRASE-NOTYPES 806 818	inflammation
T41	KEYPHRASE-NOTYPES 826 838	facial nerve
T42	KEYPHRASE-NOTYPES 846 865	geniculate ganglion
T43	KEYPHRASE-NOTYPES 875 886	compression
T44	KEYPHRASE-NOTYPES 902 910	ischemia
T45	KEYPHRASE-NOTYPES 914 927	demyelination
T46	KEYPHRASE-NOTYPES 933 941	Symptoms
T47	KEYPHRASE-NOTYPES 993 996	day
T48	KEYPHRASE-NOTYPES 1002 1006	week
T49	KEYPHRASE-NOTYPES 1040 1065	herpes simplex virus type
T50	KEYPHRASE-NOTYPES 1079 1093	causative role
T51	KEYPHRASE-NOTYPES 1107 1113	theory
T52	KEYPHRASE-NOTYPES 1126 1134	question
T53	KEYPHRASE-NOTYPES 1180 1188	patients
T54	KEYPHRASE-NOTYPES 1194 1198	Bell
T55	KEYPHRASE-NOTYPES 1201 1206	palsy
T56	KEYPHRASE-NOTYPES 1228 1236	recovery
T57	KEYPHRASE-NOTYPES 1246 1255	treatment
T58	KEYPHRASE-NOTYPES 1261 1276	corticosteroids
T59	KEYPHRASE-NOTYPES 1294 1315	antiviral medications
T60	KEYPHRASE-NOTYPES 1343 1351	outcomes
